THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT Russian patent published in 2012 - IPC A61K31/00 A61K31/506 A61K47/12 A61K47/38 A61K9/16 A61K9/22 A61K9/28 

Abstract RU 2442574 C2

FIELD: pharmaceutical industry.

SUBSTANCE: pharmaceutical composition represents a minitablet or pellet, covered with an isolating layer and enteric cover. The minitablet or pellet contains a pH-dependent medical product, preferably, dipiridamol, and the рН modifier, chosen of the group consisting the following components: lemon acid, fumaric acid, amber acid, adipic acid and maleic acid. The isolating layer includes polymer, softener and the agent reducing stickiness, and separates a minitablet or pellet from enteric covering. The рН modifier ratio to the pH-dependent medical product is from 0,2:1 to 2:1. The full liberation of the medical product from the pharmaceutical composition occurs simultaneously with the рН modifier liberation during the time periodfrom 1 till 4 hours.

EFFECT: invented pharmaceutical compositions are characterized by decrease in variability and bioavailability increase in the body of one patient or more patients.

7cl, 3 dwg, 7 ex

Similar patents RU2442574C2

Title Year Author Number
PERORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE 2017
  • Lian, Alfred Chi Ekh
  • Dingari, Venkataramana
RU2744576C2
SYSTEMS OF MEDICATION DELIVERY, INCLUDING SOLID SOLUTIONS OF WEAK-BASE MEDICATIONS 2007
  • Venkatesh Gopi
  • Boltri Luidzhi
  • Kolombo Italo
  • Lai Dzin-Vang
  • Flabiani Flavio
  • Mapelli Luidzhi
RU2434630C2
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING 2004
  • Srinivas Irukulla
  • Diksit Akhilesh Ashok
  • Reddi Pallempalli Venkata Siva
  • Reddi Billa Pravin
  • Mokhan Mehjlatur Sivaraman
  • Ravinder Kodipjaka
  • Nasare Vidzhej
  • Pergament Ehduard
RU2375048C2
TERBINAFINE SOLID MEDICINAL FORMULATION FOR ORAL ADMINISTRATION 2002
  • Alles Rajner
  • Bekker Diter
  • Bonni Zhan-Dan'El'
  • Khirsh Shtefan
  • Kal'B Oskar
  • Kelle Ehrnst Ul'Rikh
  • Majer Fridrikh Karl
  • Shtjutts Anton
  • Uill'Jams Antoni
RU2298402C2
SOLID PHARMACEUTICAL PREPARATIVE FORMULATIONS WITH CONTROLLED RELEASE BASED ON CYCLODEXTRIN SULFOALKYL ESTERS 2000
  • Stella Valentino Dzh.
  • Radzhevski Rodzher A.
  • Rao Venkatramana M.
  • Makginiti Dzhejms V.
  • Mosher Gerol'D L.
RU2233176C9
CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION 2010
  • Boldkhane Sandzhaj
  • Jatkhar Skhripad
  • Nerurkar Manish
RU2571067C2
DOSAGE FORM WITH IMPROVED CHARACTERISTICS OF pH-DEPENDENT RELEASE OF PREPARATION CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 2017
  • Kwon, Taek Kwan
  • Lee, Kwang Young
  • Im, Ho Taek
  • Kim, Yong Il
  • Park, Jae Hyun
  • Woo, Jong Soo
RU2716025C1
PHARMACEUTICAL COMPOSITIONS WITH DEFERRED RELEASE CONTAINING VALPROIC ACID AND THEIR USE 2017
  • Gustafsson, Nils Ove
  • Martensson, Khans Rodzher Markus
  • Bergkh, Niklas
  • Sejo, Jonas Fejerson
  • Jern, Sverker
RU2760304C2
ORAL PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE 2017
  • Lian Alfred Chi Ekh
  • Dingari Venkataramana
RU2738114C2
COMPOSITIONS CONTAINING WEAKLY BASIC DRUG SUBSTANCES, AND CONTROLLED-RELEASE DOSAGE FORMS 2009
  • Venkatesh Gopi
  • Lai Dzin-Vang
  • Stivens Filip Dzh.
RU2548748C2

RU 2 442 574 C2

Authors

Kramer Andrea

Ljukel' Barbara

Ris Angelika

Zipe Shtefani

Dates

2012-02-20Published

2006-08-22Filed